Clinical trial
Stem Cell Therapy to Improve Myocardial Function in Patients Undergoing Coronary…
NCT00395811 · China National Center for Cardiovascular Diseases, Other · Unknown status
Key facts
| NCT number | NCT00395811 |
|---|---|
| Title | Stem Cell Therapy to Improve Myocardial Function in Patients Undergoing Coronary Artery Bypass Grafting (CABG) |
| Lead sponsor | China National Center for Cardiovascular Diseases, Other |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Coronary Disease, Myocardial Infarction |
| Intervention type | Procedure |
| Interventions | Bone Marrow Stem Cell Therapy combined CABG |
| Enrollment | 50 |
| Start date | Jan 1, 2007 |
| Primary completion | Apr 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Nov 3, 2006 |
| Last update posted | Oct 29, 2008 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: